Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-08-12

Clinical Trial Update: Mepivacaine Versus Low-Dose Bupivacaine For Primary Total Hip and Knee Arthroplasty [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial comparing mepivacaine to low-dose bupivacaine for anesthesia in primary total hip and knee arthroplasty has completed phase 2/phase 3 with resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mepivacaine (mepivacaine)
  • bupivacaine (low-dose) (bupivacaine)

Snippet

Sponsor: Mayo Clinic | Conditions: Knee Osteoarthritis, Hip Osteoarthritis | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2021-08-12